MIFLONID 400

400MCG INH PLV CPS DUR 120

SÚKL code 0016308
Name of the product MIFLONID 400
_MA_MEDICATION_DETAIL_INFO_MED_NAME i MIFLONID 400
Supplement 400MCG INH PLV CPS DUR 120
Strenght 400MCG
Pharmaceutical form Inhalation powder, hard capsule
Package 120
Route Inhalation use
Language of the pack Czech
Wrap type Tablet container
Legal status na lékařský předpis
Active substance BUDESONIDE (BUDESONIDUM)
ATC group R03BA02
ATC group name BUDESONID

Marketing authorisation information

Registration Number 14/ 233/00-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 03. 2017
MA Holder Novartis s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Novartis s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list